No Picture
Trading Ideas

‘We’re in unusual market conditions right now’ which triggered the circuit breakers: President of the New York Stock Exchange

Stacey Cunningham, President of the New York Stock Exchange, joins Yahoo Finance’s Ines Ferre to discuss the impact of the coronavirus on the markets and what procedures are in place to prevent further declines. …read more […]

No Picture
Trading Ideas

Coronavirus combined with zero interest rates 'really worries me,' Bridgewater's Dalio says

Billionaire investor Ray Dalio, whose main Bridgewater Associates LP hedge fund fell sharply amid the coronavirus-led market rout, is concerned about the combination of zero interest rate policy and the growing health pandemic, he said in a note Monday. “I have been concerned that when the economic downturn would come, it would lead to hitting the 0% interest rate in an economic downturn with a lot of debt outstanding and big wealth and political gaps the way that configuration of events happened the 1930s,” Dalio wrote. On Sunday, the U.S. Federal Reserve cut interest rates to a target …read more […]

No Picture
Trading Ideas

Stocks That Have Dropped The Most – 2020 Update

Due to recent events, investors are wondering “what are the stocks that have dropped the most?”

For over a month now the stock market has been declining. On February 12th, the Dow Jones Industrial Average hit an all time high at 29,568.57. Since then, just one month later, the Dow has dropped all the way down to 21,154.46. This news triggered the announcement of a bear market, the first since 2009. However, following President Trump’s speech on Friday, the market did get a nice boost, rallying back to 23,173.99. President Trump was quite proud of this, announcing the “BIGGEST STOCK MARKET …read more […]

No Picture
Trading Ideas

It’s Too Early to Tell If Inovio (INO) Is a COVID-19 Play, Says Analyst

The novel coronavirus is dominating headlines around the world right now. But in Maxim Group’s latest report on Inovio Pharmaceuticals (INO), COVID-19 merits hardly a mention. Turns out, Maxim loves this stock, but not only because of Coronavirus.In Maxim’s note, analyst Jason McCarthy notes that “it’s too early to tell” if Inovio is “a COVID-19 play.” On the one hand, “Inovio has rapidly developed its DNA-based COVID-19 vaccine, INO-4800.” Within just three hours of receiving its first sample of the virus’s genetic sequence, Inovio already had the vaccine candidate prepared “using its DNA-based vaccine platform,” and began “preclinical development.”Like Novavax …read more […]